J.P. Morgan closes derivative contract in Kangji Medical privatization

J.P. Morgan Securities PLC, an associate connected with the offeror, disclosed dealings in Kangji Medical Holdings Limited shares as part of the company's privatization by way of a scheme of arrangement. The transaction, dated October 14, 2025, involved the closing out of a derivative contract related to other types of products.

The dealing concerned 5,500 reference securities, with a maturity/closing out date of September 24, 2027. The reference price for this transaction was $8.8968, resulting in a total amount paid/received of $48,932.40. Following this dealing, the resultant balance for J.P. Morgan Securities PLC stands at 10,768,360.

The disclosure specifies that these dealings were made for J.P. Morgan Securities PLC's own account. J.P. Morgan Securities PLC is ultimately owned by JPMorgan Chase & Co.